Search research articles
Contact Us
Filters
Showing results (181-190 of 5,434) with videos related to
Page
of 544
Sort By:
Ugeskrift for Laeger
|
June 25, 1973
[Vincristine sulfas (Oncovin), a cytostatic agent]
N I Nissen
The American Journal of Cardiology
|
August 30, 2005
Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial
Steven E Nissen
Physical Review. B, Condensed Matter
|
April 15, 1990
Photoluminescence from excitons bound to a triple acceptor, Ge:Cu
Nissen, Steele, Thewalt
Journal of the American College of Cardiology
|
May 10, 2006
President's page: American College of Cardiology fellowship: where ideals and personal responsibility intersect
Steven E Nissen,
Journal of the American College of Cardiology
|
February 6, 2007
President's page: the ACC's international mission: learning, leading, and sharing
Steven E Nissen
Lancet (London, England)
|
December 13, 2006
The DREAM trial
Steven E Nissen
Journal of Psychoactive Drugs
|
May 26, 2007
Reclaiming futures: communities helping teens overcome drugs, alcohol and crime--a new practice framework for juvenile justice
Laura Burney Nissen
The New England Journal of Medicine
|
June 28, 2006
Adverse cardiovascular effects of rofecoxib
Steven E Nissen
BMJ (Clinical Research Ed.)
|
December 17, 2013
Rosiglitazone: a case of regulatory hubris
Steven E Nissen
Annals of Internal Medicine
|
May 8, 2023
Comparative Effectiveness of Diabetes Drugs: The Use and Misuse of Observational Research
Steven E Nissen
Page
of 544
Search research articles
Search
Showing results (181-190 of 5,434) with videos related to
Sort By:
Page
of 544
Ugeskrift for Laeger
|
June 25, 1973
[Vincristine sulfas (Oncovin), a cytostatic agent]
N I Nissen
The American Journal of Cardiology
|
August 30, 2005
Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial
Steven E Nissen
Physical Review. B, Condensed Matter
|
April 15, 1990
Photoluminescence from excitons bound to a triple acceptor, Ge:Cu
Nissen, Steele, Thewalt
Journal of the American College of Cardiology
|
May 10, 2006
President's page: American College of Cardiology fellowship: where ideals and personal responsibility intersect
Steven E Nissen,
Journal of the American College of Cardiology
|
February 6, 2007
President's page: the ACC's international mission: learning, leading, and sharing
Steven E Nissen
Lancet (London, England)
|
December 13, 2006
The DREAM trial
Steven E Nissen
Journal of Psychoactive Drugs
|
May 26, 2007
Reclaiming futures: communities helping teens overcome drugs, alcohol and crime--a new practice framework for juvenile justice
Laura Burney Nissen
The New England Journal of Medicine
|
June 28, 2006
Adverse cardiovascular effects of rofecoxib
Steven E Nissen
BMJ (Clinical Research Ed.)
|
December 17, 2013
Rosiglitazone: a case of regulatory hubris
Steven E Nissen
Annals of Internal Medicine
|
May 8, 2023
Comparative Effectiveness of Diabetes Drugs: The Use and Misuse of Observational Research
Steven E Nissen
Page
of 544